ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,446.68
      -1.37%
      US Tech 100
      18,309.60
      -2.83%
      Dow Jones
      40,347.97
      -1.21%
      Brent Oil
      79.97
      -1.89%
      Bitcoin
      65,240.03
      0.99%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. G1 Therapeutics Inc (GTHX)

      7. G1 Therapeutics Inc (GTHX) Financials

      G1 Therapeutics Inc

      G1 Therapeutics Inc (GTHX)

      NASDAQ
      4.20
      -0.09
      (-2.10%)
      At close: August 01 4:00PM
      Delayed by 15 minutes
      4.18
      -0.02
      ( -0.48% )
      After Hours: 5:45PM
      Delayed by 15 minutes

      G1 Therapeutics Inc Financial Summary

      The current GTHX market cap is 218.54M. The company's latest EPS is USD -0.9175 and P/E is -4.57.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 12.95M42.39M12.3M14.87M14.48M
      Operating Income -25.75M12.61M-16.37M-8.93M-9.05M
      Net Income -27.6M8.71M-18.2M-10.88M-10.22M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 045.29M31.48M51.3M82.51M
      Operating Income -129.04M-96.48M-142.46M-136.18M-39.53M
      Net Income -122.45M-99.25M-148.35M-147.56M-47.97M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 161.96M147.89M133.1M121.54M102.03M
      Total Liabilities 116.97M90.34M90.08M86.15M74.29M
      Total Equity 44.99M57.55M43.02M35.39M27.74M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 284.83M228.55M254.09M187.97M121.54M
      Total Liabilities 29.3M51.2M110.55M119.22M86.15M
      Total Equity 255.53M177.35M143.54M68.75M35.39M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -29.05M-14.97M-25.55M-38.34M-8.9M
      Investing 2.91M3.26M10.46M2.81M5.29M
      Financing -214k-26.97M-26.95M-26.91M-8.72M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -99.57M-83.74M-132.11M-128.62M-38.34M
      Investing -2.72M152k N/A -50.53M2.81M
      Financing 2.71M21.69M145.86M52.5M-26.91M

      Stats and Ratios

      Market Cap 218.54M
      Price to Earnings Ratio -4.57
      Price to Sales Ratio 2.65
      Price to Cash Ratio 6.8
      Price to Book Ratio 6.19
      Dividend Yield -

      Share Statistics

      Shares Outstanding 52.28M
      Average Volume (1 week) 1.08M
      Average Volume (1 Month) 949.88k
      52 Week Change 75.63%
      52 Week High 6.14
      52 Week Low 1.08
      Spread (Intraday) 0.09 (2.1%)

      Company Info

      Company Name G1 Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.g1therapeutics.com
      Industry pharmaceutical preparations (2834)